Mapping Rheumatoid Arthritis

Big day today.

The "RA-MAP Universe" will be unveiled for the first time at EULAR 2019 in Madrid.

The first complete network map of systems involved in early rheumatoid arthritis.

RA Predictors of Remission

And for those who missed it the first time around, here is the link to clinical trajectories paper.

RMD Open. 2018 Oct 25;4(2):e000721. doi: 10.1136/rmdopen-2018-000721. 

Novel methodology to discern predictors of remission and patterns of disease activity over time using rheumatoid arthritis clinical trials data.

https://www.ncbi.nlm.nih.gov/pubmed/30487994

Good News: RA-MAP joins IMID-Bio

As many will know the RA-MAP consortium has joined forces with other consortia to better understand immune-mediated inflammatory diseases.

The IMID-BIO project brings together a number of consortia from across the UK.

This is the future of open collaborative research in science.

We are excited about this!

You can read the latest newsletter here:

 https://twitter.com/imidbio/status/1019131476363956224

And follow us on twitter @imidbio

The RA-MAP Consortium in Nature Reviews Rheumatology

The RA-MAP Consortium: a working model for academia–industry collaboration

Nature Reviews Rheumatology volume 14, pages 53–60 (2018)

doi:10.1038/nrrheum.2017.200

The first in a string of papers coming out of the RA-MAP Consortium.

Exciting Times for RA-MAP

The RA-MAP project is now entering the critical analysis and reporting stages. Already, the analysis team have some exciting insights to share with the RA research community and are busy preparing the first manuscripts for submission and peer review. 

WATCH THIS SPACE